Drugs.com - FDA MedWatch Alerts

Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag

Audience: Pharmacy, Health Care Professional March 13, 2025 -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is...

Mar 14, 2025 - 01:07
 0
Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag
Audience: Pharmacy, Health Care Professional March 13, 2025 -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is...
Read More

Tags:

Previous Article

Fragrance Brand Ourside Turns Trademark Setback Into A Community-Building Effort

Next Article

Limited Number of Voluntary Recalls Initiated after FDA Testing of Acne Products...

Related Posts

Public Safety Notification on Amniotic Fluid Eyedrops

Public Safety Notification on Amniotic Fluid Eyedrops

Feb 9, 2025  0

C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga y Omega 3 Due to the Presence of Undeclared Drug Ingredients

C&A Naturistics Issues Voluntary Nationwide Recall of A...

Feb 9, 2025  0

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic ...

Feb 9, 2025  0